Market Overview

9 Policy Catalysts For Health Care Investors To Watch Before Year's End

9 Policy Catalysts For Health Care Investors To Watch Before Year's End
Related RHHBY
These Were The 10 Most Actively Traded OTCQX and OTCQB Securities In November
New Gilead Sciences CEO Has 'Breadth Of Experience' From Time At Roche, Says Bullish Raymond James
Senate Dems introduce bill to block "excessive" increases in drug prices (Seeking Alpha)

Health care investors are entering both the final stretch of 2018 and the final weeks of a GOP-controlled House of Representatives. Height Capital Markets analyst Andrea Harris surveyed nine potential health care catalysts that investors should be watching between now and the end of December in a recent note. 

Of the nine potential legislative catalysts ahead in the next month, Harris said she expects two of them to pass: measures that would financially impact Roche Holdings AG Basel ADR Common Stock (OTC: RHHBY), Sanofi SA (NYSE: SNY), Takeda Pharmaceutical Co Ltd (OTC: TKPYY), Merck & Co., Inc. (NYSE: MRK), Cardinal Health Inc (NYSE: CAH), GlaxoSmithKline plc (NYSE: GSK), Johnson & Johnson (NYSE: JNJ), and Procter & Gamble Co (NYSE: PG).

Two Imminent Measures

“We believe that a reauthorization of the Pandemic and All-Hazards Preparedness Act (S. 2852) and the Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 (H.R. 5333) stand the best chance of passage this year,” Harris said. 

Other key pieces of health care legislation might still make it through in 2019 as well, the analyst said. 

“We further believe that legislation to address health care taxes (device tax, Cadillac tax and the health insurer fee) and drug pricing legislation (BBA fix, TrOOP cliff fix, and CREATES Act) are possible to enact in 2018, but Congress will more likely address these issues in 2019." 

Other Impacted Stocks

Other pieces of legislation could impact additional companies, Harris said: 

  • Anthem Inc (NYSE: ANTM)
  • Aetna Inc (NYSE: AET)
  • CIGNA Corporation (NYSE: CI)
  • Humana Inc (NYSE: HUM)
  • Centene Corp (NYSE: CNC)
  • Molina Healthcare, Inc. (NYSE: MOH)
  • UnitedHealth Group Inc (NYSE: UNH)
  • WellCare Health Plans, Inc. (NYSE: WCG)
  • Becton Dickinson and Co (NYSE: BDX)
  • Boston Scientific Corporation (NYSE: BSX)
  • Edwards Lifesciences Corp (NYSE: EW)
  • Medtronic PLC (NYSE: MDT)
  • Stryker Corporation (NYSE: SYK)
  • Mylan NV (NASDAQ: MYL)
  • Teva Pharmaceutical Industries Ltd ADR (NYSE: TEVA)
  • Celgene Corporation (NASDAQ: CELG)
  • Gilead Sciences, Inc. (NASDAQ: GILD)
  • Amgen, Inc. (NASDAQ: AMGN)
  • AbbVie Inc (NYSE: ABBV)
  • Pfizer Inc. (NYSE: PFE)
  • Healthequity Inc (NASDAQ: HQY)
  • UnitedHealth Group Inc (NYSE: UNH)
  • Webster Financial Corporation (NYSE: WBS)

The Height Capital chart below indicates which legislative measures the firm believes are likely to pass and which specific stocks could be impacted:

Related Links:

The Health Care Stocks With A Lot Riding On The Midterm Elections

With Tether In Focus, The DoJ Is Investigating Last Year's Cryptomania

Latest Ratings for RHHBY

Nov 2018Goldman SachsDowngradesConviction BuyBuy
May 2018Credit SuisseDowngradesNeutralUnderperform
May 2018BernsteinDowngradesOutperformMarket Perform

View More Analyst Ratings for RHHBY
View the Latest Analyst Ratings

Posted-In: Andrea Harris Height Capital MarketsAnalyst Color Health Care Politics Analyst Ratings Trading Ideas General Best of Benzinga


Related Articles (AET + ABBV)

View Comments and Join the Discussion!

Latest Ratings

SYBXChardan CapitalInitiates Coverage On20.0
GEJP MorganUpgrades6.0
FEYEMorgan StanleyDowngrades21.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings

Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week